Skip to main content

Table 2 Structural formulas of PI3K inhibitors

From: Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development

Classification

Compound

Structural formula

Compound

Structural formula

Pan-PI3K inhibitors

Pictilisib (GDC-0941)

Copanlisib (BAY 80–6946)

Taselisib (GDC-0032)

Sonolisib (PX-866)

Buparlisib (BKM120)

ZSTK474

Pilaralisib (XL147, SAR245408)

AMG 511

Isoform-selective inhibitors

Alpelisib (BYL719)

CH5132799

Idelalisib (CAL-101, GS-1101)

AS-605240

AMG319

MLN1117 (INK1117)

AZD6482

  

Dual PI3K/mTOR inhibitors

Dactolisib (NVP-BEZ235)

GDC-0084 (RG7666)

NVP-BGT226

VS-5584 (SB2343)

Omipalisib (GSK2126458, GSK458)

PF-04691502

GSK1059615

Gedatolisib (PF-05212384, PKI-587)

Voxtalisib (XL765, SAR245409)

PQR309

Apitolisib (GDC-0980)

 Â